RxDoctor Payments Data

Ann Maria Elder, MD

Physical Medicine & Rehabilitation · Ludlow, MANPI 1720064983

Payments from drug & device makers

$259in general payments, 2019–2025

Across 9 payments — averaging $28.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$116
  • Neurocrine Biosciences, Inc.$33
  • Lundbeck LLC$21
  • Smith+Nephew$21
  • Novartis$20
  • Abbott$19
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$259100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$259 in reported general payments places this provider in the 65th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.

See all physical medicine & rehabilitation providers in Massachusetts

Medicare billing

Part B allowed, 2024
$389,720
Medicare patients
1,454
Services billed
3,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,629$397,240
NuplazidPimavanserin Tartrate42$191,290
Trelegy ElliptaFluticasone/Umeclidin/Vilanter104$67,965
TrulicityDulaglutide88$61,464
BiktarvyBictegrav/Emtricit/Tenofov Ala25$38,737
XareltoRivaroxaban163$37,960
MyrbetriqMirabegron148$33,496
GenvoyaElviteg/Cob/Emtri/Tenof Alafen14$27,522
JanuviaSitagliptin Phosphate123$24,847
FarxigaDapagliflozin Propanediol108$24,512
EntrestoSacubitril/Valsartan77$23,201
Breo ElliptaFluticasone/Vilanterol52$22,165
Atorvastatin Calcium1,982$19,946
Actemra ActpenTocilizumab14$17,945
Sevelamer Hcl68$17,418

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$116$191,29042 claims
Johnson & JohnsonXarelto, Procrit$14$53,403178 claims
NovartisEntresto$20$23,20177 claims
Smith+NephewSantyl$21$10,79533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.

Other physical medicine & rehabilitation in Ludlow

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →